Details of the Drug Combinations

General Information of This Drug (ID: DMHY3IP)

Drug Name

Lobeglitazone DMHY3IP

Synonyms

Lobeglitazone sulfate; CKD-501; Dual PPARalpha/delta (type 2 diabetes), Chong Kun Dang

Indication

Disease Entry	ICD 11	Status	REF
Type-2 diabetes	5A11	Approved	[1]
------------------------------------------------------------------------------------

Drug Type

Small molecular drug

Structure

3D MOL

2D MOL

List of Combinatorial Drugs (CBD) Containing This Drug

1 Clinical Trial Drug Combination(s) Consisting of This drug

DrugCom Name	DrugCom ID	Component Drug	Indication	REF
Lobeglitazone + Empagliflozin	DCIATLI	Empagliflozin	Diabetes Mellitus, Type II	[2]
------------------------------------------------------------------------------------

References

1	Tolerability and pharmacokinetics of lobeglitazone, a novel peroxisome proliferator-activated receptor-gamma agonist, after a single oral administration in healthy female subjects. Clin Drug Investig. 2014 Jul;34(7):467-74.
2	ClinicalTrials.gov (NCT02854748) Evaluate the Drug-drugs Interaction Between Lobeglitazone and Empagliflozin